Postmenopausal dyspareunia: has the Food and Drug Administration really helped?
- PMID: 23676631
- DOI: 10.1097/GME.0b013e318291ef83
Postmenopausal dyspareunia: has the Food and Drug Administration really helped?
Comment on
-
Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.Menopause. 2013 Jun;20(6):623-30. doi: 10.1097/gme.0b013e318279ba64. Menopause. 2013. PMID: 23361170 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical